PART II: Implications of plasmid DNA fragments in blood products

Experts say there are significant blind spots in the oversight of blood products, leaving the public in a dangerous state of speculation.

Part I of this investigation examined the findings of researcher Sandeep Chakraborty, who identified unexpected DNA sequences in the blood of individuals vaccinated with mRNA COVID-19 vaccines—sequences that should not have been present.

The detection of gene fragments encoding 'SV40' and 'Kanamycin,' which are specific to the plasmid DNA used in vaccine manufacturing, has now raised significant concerns about the safety of blood products.

If these genetic sequences can persist in the bloodstream after vaccination, and potentially end up in blood products such as fresh frozen plasma, whole blood, or cryoprecipitate, what risks might they pose to recipients?"

Experts in blood safety are now questioning whether Australia’s current blood donation and monitoring systems are sufficiently equipped to manage these potential health risks.